Navigating EU Challenges: Strategies for Biological Companies to Succeed

Staphyt’s Geoffroy Moulin highlights the EU’s push to fast-track biocontrol product approvals, despite ongoing challenges.

AXPERA is an amoeba lysate-based biofungicide for combating fungal diseases.

Director of Field Solutions Matt Sowder discusses what it takes to get growers and retailers to put their trust in new products.

Kynetec’s Warrick Steptoe shares analysis of farmer-sourced biostimulant market data at the Biostimulants World Congress.

The industry is anticipated to record an 8.5% CAGR during 2024-2032 due to a wider awareness of sustainable ag practices.

Membership strengthens its commitment to sustainability and responsibility in the agricultural sector.

The YaraAmplix portfolio is designed to enhance crop resilience, nutrient uptake, and overall crop quality while promoting healthier soils.

Experts share their perspectives on what’s working in this region as well as potential hurdles companies should be aware of.

Experts offer insights on the U.S. biologicals market and discuss opportunities for companies looking to market their products.